The Truth Gender Clinicians Tried to Ignore - Dr Susan Bradley (#43)

16 October 2025

With Dr Susan Bradley

58 minutes

Dr Susan Bradley spent nearly five decades treating gender-dysphoric children at the Toronto clinic she co-founded in 1975. In this conversation with the Beyond Gender hosts, she reflects on what the evidence actually showed — and why she believes the field took a catastrophically wrong turn. This is the testimony of a genuine insider: a clinician who watched her discipline drift away from its own data, and who is prepared to say so plainly.

There are clinicians who speak out about gender medicine early in their careers, before the professional costs become clear. Dr Susan Bradley is not one of them. She spent nearly five decades at the centre of this field — co-founding Toronto's first paediatric gender clinic in 1975, treating more than four hundred gender-dysphoric children, and chairing the DSM-IV subcommittee on sexual and gender identity disorders. When she speaks in this episode, she is not speculating from the outside. She is reporting from within a half-century of clinical experience, and the Beyond Gender hosts give her the space to do exactly that. What that experience showed, again and again, was a pattern the wider field seemed determined not to discuss. The overwhelming majority of gender-dysphoric children who came through her clinic turned out, as adults, to be gay or lesbian. The dysphoria was real. The suffering was real. But the destination was rarely the one the emerging trans-affirmative model assumed. Bradley names this plainly, without hedging, and Stella, Mia and Bret press her carefully on what it means for how clinicians should be responding to these young people today. She is equally direct on puberty blockers. The Dutch clinic and the endocrinologists who pioneered their use promised they were safe, reversible, and would give young people time to think. Bradley's assessment is blunt: they were not reversible, and they did not function as a pause. Once children began blockers, roughly ninety percent went on to cross-sex hormones. The pause-button framing, she suggests, was a clinical fiction — one that shaped policy across the Western world before the evidence was in. Bradley shares two patient histories that stay with you long after the episode ends. The first is a boy who arrived at the clinic at nine, convinced he needed to be a girl. Years later he told her he wasn't trans — he was gay. What made the difference wasn't any therapeutic technique. He attended a gay youth group, met someone who cared about him, and the conviction simply dissolved. The second is her very first patient: a man who transitioned at eighteen in the late 1970s and who, at seventy — after his wife had died — spent twenty thousand dollars on further surgery, still searching for a sense of completeness that never came. The broader institutional story she tells is one of field-wide suppression. In 2015, her colleague Ken Zucker — who ran the gender identity clinic at CAMH in Toronto and had decades of peer-reviewed research behind him — was fired following activist pressure, his work labelled conversion therapy. The charges did not hold. CAMH later issued a formal apology and paid a substantial settlement. Bradley watched this happen and understood what it signalled: the field had stopped following the data and started policing those who tried to. What makes this conversation so valuable is Bradley's willingness to apply that same scrutiny to her own profession's assumptions. The field, she says, was wrong to treat every gender-dysphoric child as someone on a path toward a trans identity — and the cost of that error, measured in real lives, has been enormous. It is a rare thing to hear someone with her standing say it so directly, and the hosts handle the conversation with the seriousness it deserves.

More recent episodes